Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
European Urology|June 17, 2014
Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database ConsortiumDaniel Y C Heng, J Connor Wells, Brian I Rini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2016
Docetaxel As Monotherapy or Combined With Ramucirumab or Icrucumab in Second-Line Treatment for Locally Advanced or Metastatic Urothelial Carcinoma: An Open-Label, Three-Arm, Randomized Controlled Phase II TrialDaniel P Petrylak, Scott T Tagawa, Manish Kohli, et al.
Bone Marrow Transplantation|January 4, 2024
Long-term outcomes of patients with large B-cell lymphoma treated with axicabtagene ciloleucel and prophylactic corticosteroidsOlalekan O Oluwole, Edouard Forcade, Javier Muñoz, et al.
British Journal of Haematology|July 23, 2021
Prophylactic corticosteroid use in patients receiving axicabtagene ciloleucel for large B-cell lymphomaOlalekan O Oluwole, Krimo Bouabdallah, Javier Muñoz, et al.
Blood|February 23, 2023
Five-year follow-up of ZUMA-1 supports the curative potential of axicabtagene ciloleucel in refractory large B-cell lymphomaSattva S Neelapu, Caron A Jacobson, Armin Ghobadi, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 19, 2015
Testicular Cancer, Version 2.2015Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
The Lancet. Oncology|December 7, 2018
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trialFrederick L Locke, Armin Ghobadi, Caron A Jacobson, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 19, 2015
Kidney cancer, version 3.2015Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 4, 2014
Kidney cancer, version 2.2014Robert J Motzer, Eric Jonasch, Neeraj Agarwal, et al.
Experimental Hematology & Oncology|April 30, 2025
Hypomagnesemia in lymphoma patients receiving CAR T therapy correlates with immune dysfunction and decreased survivalJennifer J Gile, Patrizia Mondello, Zixing Wang, et al.
Pageof 6